223 related articles for article (PubMed ID: 11703656)
1. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
Upton AM; Mushtaq A; Victor TC; Sampson SL; Sandy J; Smith DM; van Helden PV; Sim E
Mol Microbiol; 2001 Oct; 42(2):309-17. PubMed ID: 11703656
[TBL] [Abstract][Full Text] [Related]
2. Mutational and expression analysis of tbnat and its response to isoniazid.
Sholto-Douglas-Vernon C; Sandy J; Victor TC; Sim E; Helden PD
J Med Microbiol; 2005 Dec; 54(Pt 12):1189-1197. PubMed ID: 16278433
[TBL] [Abstract][Full Text] [Related]
3. Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
Kawamura A; Sandy J; Upton A; Noble M; Sim E
Protein Expr Purif; 2003 Jan; 27(1):75-84. PubMed ID: 12509987
[TBL] [Abstract][Full Text] [Related]
4. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E
Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Payton M; Auty R; Delgoda R; Everett M; Sim E
J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferases: from structure to function.
Sim E; Walters K; Boukouvala S
Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
[TBL] [Abstract][Full Text] [Related]
7. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferases in mycobacteria.
Sim E; Sandy J; Evangelopoulos D; Fullam E; Bhakta S; Westwood I; Krylova A; Lack N; Noble M
Curr Drug Metab; 2008 Jul; 9(6):510-9. PubMed ID: 18680471
[TBL] [Abstract][Full Text] [Related]
10. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
Sim E; Abuhammad A; Ryan A
Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
[TBL] [Abstract][Full Text] [Related]
13. [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
Augustynowicz-Kopeć E; Zabost A; Kozińska M; Brzezińska S; Zwolska Z
Pneumonol Alergol Pol; 2007; 75(2):134-9. PubMed ID: 17973219
[TBL] [Abstract][Full Text] [Related]
14. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.
Sandy J; Holton S; Fullam E; Sim E; Noble M
Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451
[TBL] [Abstract][Full Text] [Related]
15. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
[TBL] [Abstract][Full Text] [Related]
16. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
17. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.
Ramos RM; Perez JM; Baptista LA; de Amorim HL
J Mol Model; 2012 Sep; 18(9):4013-24. PubMed ID: 22460521
[TBL] [Abstract][Full Text] [Related]
18. NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium.
Delgoda R; Lian LY; Sandy J; Sim E
Biochim Biophys Acta; 2003 Mar; 1620(1-3):8-14. PubMed ID: 12595067
[TBL] [Abstract][Full Text] [Related]
19. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]